The CorEvitas Psoriasis (PSO) Registry
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The primary objective of the CorEvitas Psoriasis Registry is to study the comparative safety of approved psoriasis therapies in a North American cohort of psoriasis subjects treated by dermatologists. This includes assessing the incidence and nature of adverse events of special interest, including malignancy, in a real world population of psoriasis patients on new biologic therapies (e.g. secukinumab). Secondary objectives include analyzing the epidemiology and natural history of the disease, comorbidities, current treatment practices, and comparative effectiveness.
Sponsor: CorEvitas
You may qualify if…
- ✓ The patient must:
- ✓ 1. Have been diagnosed with psoriasis by a dermatologist.
- ✓ 2. Be at least 18 years of age or older.
- ✓ 3. Be willing and able to provide written consent for participation in the registry.
- ✓ 4. Be willing and able to provide Personally Identifiable Information (PII) that includes the following types of personal information at a minimum: 1) Full Name and 2) Date of Birth.
- ✓ 5. Meet one of the following criteria.
- ✓ Have started on or switched to a systemic psoriasis treatment within the previous 12 months†▲:
You may not qualify if…
- ✕ 1\. Patient is participating in or planning to participate in a double-blind randomized of a psoriasis drug. Of note, concurrent participation in another observational registry or open-label Phase 3b/4 trial is not excluded.
Where it's recruiting
Waltham
Source: ClinicalTrials.gov · NCT02707341 · last updated 2026-08-27